<DOC>
	<DOC>NCT00687973</DOC>
	<brief_summary>Assess that for an equivalent brachial blood pressure (BP)lowering, a fixed dose combination amlodipine/valsartan based regimen reduces central aortic BP pressure to a larger extent than an atenolol/amlodipine combination based regimen.</brief_summary>
	<brief_title>Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine, Valsartan Drug Combination</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Male or female patients 18 years of age or older Hypertension defined by MSDBP &gt; 90 and or MSSBP &gt; 140 mmHg, MSDBP &gt; 80 mmHg, or/and MSSBP &gt; 130 mmHg if diabetes or chronic renal impairment uncontrolled under their previous therapy, or untreated , or experiencing unacceptable side effects Written informed consent to participate in the study prior to any study procedures Severe hypertension (grade 3 WHO classification MSDBP &gt; 110 mmHg and/or MSSBP &gt; 180 mmHg) Evidence of a secondary form of hypertension Type 1 diabetes mellitus History of congestive heart failure, unstable coronary insufficiency, life threatening arrhythmia, significant valvular disease, second or third degree heart block etc.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>